PHASE I/II STUDY OF DDFPe AS A RADIOSENSITIZER IN GLIOBLASTOMA

被引：0
|
作者：
Unger, Evan [1 ]
Mason, Ralph [2 ,3 ]
Zhou, Heling [3 ]
Sellenger, Michael [4 ]
Ruben, Jeremy [5 ]
Lickliter, Jason [6 ]
Longacre, Olivia [7 ]
机构：
[1] Univ Arizona, Tucson, AZ USA
[2] UT Southwestern, Dept Radiol, Dallas, TX USA
[3] UT Southwestern, Dallas, TX USA
[4] Alfred Hosp, Melbourne, Vic, Australia
[5] Alfred RANZCR Training Network, William Buckland Radiotherapy Ctr, Melbourne, Vic, Australia
[6] Monash Univ, Melbourne, Vic, Australia
[7] NuvOx Pharma, Tucson, AZ USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RTHP-27
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of VAL-083 in patients with recurrent glioblastoma.
    Shih, Kent C.
    Patel, Manish R.
    Butowski, Nicholas A.
    Falchook, Gerald Steven
    Kizilbash, Sani Haider
    Bacha, Jeffrey A.
    Brown, Dennis
    Steino, Anne
    Schwartz, Richard Stephen
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] INTRAGO: intraoperative radiotherapy in glioblastoma multiforme - a Phase I/II dose escalation study
    Giordano, Frank A.
    Brehmer, Stefanie
    Abo-Madyan, Yasser
    Welzel, Grit
    Sperk, Elena
    Keller, Anke
    Schneider, Frank
    Clausen, Sven
    Herskind, Carsten
    Schmiedek, Peter
    Wenz, Frederik
    BMC CANCER, 2014, 14
  • [23] Interim Analysis of a Phase I/II Study of Panobinostat in Combination with Bevacizumab for Recurrent Glioblastoma
    Lee, Eudocia
    Reardon, David
    Schiff, David
    Drappatz, Jan
    Hammond, Samantha
    Grimm, Sean
    Norden, Andrew
    Beroukhim, Rameen
    McCluskey, Christine
    Chi, Andrew
    Batchelor, Tracy
    Doherty, Lisa
    Lafrankie, Debra
    Ruland, Sandra
    Rifenburg, Jennifer
    Jacobs, Jeanne
    Smith, Katrina
    Gaffey, Sarah
    Gerard, Mary
    Snodgrass, Susan
    Raizer, Jeffrey
    Wen, Patrick
    NEUROLOGY, 2013, 80
  • [24] Phase I/II study of VAL-083 in patients with recurrent glioblastoma multiforme
    Shih, Kent C.
    Patel, Manish R.
    Bacha, Jeffrey
    Brown, Dennis M.
    Garner, William J.
    Steino, Anne
    Schwartz, Richard S.
    Kanekal, Sarath
    Li, Mike
    Lopez, Lorena M.
    Burris, Howard A.
    CANCER RESEARCH, 2014, 74 (19)
  • [25] Interim analysis of a phase I/II study of panobinostat in combination with bevacizumab for recurrent glioblastoma
    Lee, Eudocia Quant
    Reardon, David A.
    Schiff, David
    Drappatz, Jan
    Muzikansky, Alona
    Hammond, Samantha
    Grimm, Sean Aaron
    Norden, Andrew David
    Beroukhim, Rameen
    McCluskey, Christine Sceppa
    Chi, Andrew S.
    Batchelor, Tracy
    Smith, Katrina H.
    Gaffey, Sarah C.
    Gerard, Mary
    Snodgrass, Susan M.
    Raizer, Jeffrey J.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Interim Analysis of a Phase I/II Study of Panobinostat in Combination with Bevacizumab for Recurrent Glioblastoma
    Lee, Eudocia
    Reardon, David
    Schiff, David
    Drappatz, Jan
    Hammond, Samantha
    Grimm, Sean
    Norden, Andrew
    Beroukhim, Rameen
    McCluskey, Christine
    Chi, Andrew
    Batchelor, Tracy
    Doherty, Lisa
    Lafrankie, Debra
    Ruland, Sandra
    Rifenburg, Jennifer
    Jacobs, Jeanne
    Smith, Katrina
    Gaffey, Sarah
    Gerard, Mary
    Snodgrass, Susan
    Raizer, Jeffrey
    Wen, Patrick
    NEUROLOGY, 2013, 80
  • [27] INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study
    Frank A Giordano
    Stefanie Brehmer
    Yasser Abo-Madyan
    Grit Welzel
    Elena Sperk
    Anke Keller
    Frank Schneider
    Sven Clausen
    Carsten Herskind
    Peter Schmiedek
    Frederik Wenz
    BMC Cancer, 14
  • [28] Phase II study of Dovitinib in recurrent glioblastoma
    Mayur Sharma
    Cathy Schilero
    David M. Peereboom
    Brian P. Hobbs
    Paul Elson
    Glen H. J. Stevens
    Keith McCrae
    Andrew B. Nixon
    Manmeet S. Ahluwalia
    Journal of Neuro-Oncology, 2019, 144 : 359 - 368
  • [29] Phase II study of Dovitinib in recurrent glioblastoma
    Sharma, Mayur
    Schilero, Cathy
    Peereboom, David M.
    Hobbs, Brian P.
    Elson, Paul
    Stevens, Glen H. J.
    McCrae, Keith
    Nixon, Andrew B.
    Ahluwalia, Manmeet S.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 144 (02) : 359 - 368
  • [30] Phase I/II Trial on Intraoperative Radiotherapy (IORT) in Glioblastoma Multiforme (INTRAGO I/II)
    Giordano, F.
    Brehmer, S.
    Muerle, B.
    Welzel, G.
    Sperk, E.
    Keller, A.
    Abo-Madyan, Y.
    Clausen, S.
    Schneider, F.
    Herskind, C.
    Seiz-Rosenhagen, M.
    Groden, C.
    Schmiedek, P.
    Glas, M.
    Haenggi, D.
    Petrecca, K.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S330 - S331
12345